🇺🇸 FDA
Pipeline program

SRM003

AVF01-SRM003

Phase 2 mab completed

Quick answer

SRM003 for Arteriovenous Fistula is a Phase 2 program (mab) at Takeda with 1 ClinicalTrials.gov record(s).

Program details

Company
Takeda
Indication
Arteriovenous Fistula
Phase
Phase 2
Modality
mab
Status
completed

Clinical trials